ReviewFrontiers in medicine2020

Efficacy and Toxicity of Immune -Checkpoint Inhibitors in Patients With Preexisting Autoimmune Disorders.

Michelle Coureau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.